Keith Harshman
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- Cutaneous Melanoma Detection and Management
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- Gene expression and cancer classification 4
- Melanoma and MAPK Pathways 3
- Fungal and yeast genetics research 3
- RNA Research and Splicing 3
- Genetics 8
- Virus-based gene therapy research 3
- Co-authors
- Mark H. Skolnick (3 shared papers)Sean V. Tavtigian (3 shared papers)Alexander Kamb (3 shared papers)Jane Weaver-Feldhaus (1 shared paper)Elisabeth Stockert (1 shared paper)Rufus S. Day (1 shared paper)Bruce E. Johnson (1 shared paper)Nelleke A. Gruis (1 shared paper)
- Journals
- Nucleic Acids Research (5 papers)Science (2 papers)Eukaryotic Cell (2 papers)BioTechniques (2 papers)Journal of Virology (2 papers)
- Partner nations
- SwitzerlandUnited StatesSpain
In The Last Decade
Keith Harshman
43 papers receiving 4.9k citations
Keith Harshman's Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 1.9k
- Cancer Research 906
- Molecular Biology 3.2k
- Aging 61
- Cell Biology 462
Countries citing papers authored by Keith Harshman
This map shows the geographic impact of Keith Harshman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Harshman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Harshman more than expected).
Fields of papers citing papers by Keith Harshman
This network shows the impact of papers produced by Keith Harshman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Harshman. The network helps show where Keith Harshman may publish in the future.
Co-authors
The 25 scholars most cited alongside Keith Harshman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types Hit paper breakdown → | 1994 | 2328 |
| 2 | 2011 | 295 | |
| 3 | 1989 | 289 | |
| 4 | 1988 | 216 | |
| 5 | 1985 | 197 | |
| 6 | 2012 | 157 | |
| 7 | 2009 | 143 | |
| 8 | 1990 | 142 | |
| 9 | 2003 | 110 | |
| 10 | 2003 | 104 | |
| 11 | 2013 | 96 | |
| 12 | 2010 | 83 | |
| 13 | 1994 | 80 | |
| 14 | 2004 | 71 | |
| 15 | 2009 | 67 | |
| 16 | 2008 | 61 | |
| 17 | 2005 | 52 | |
| 18 | 2011 | 47 | |
| 19 | 2000 | 43 | |
| 20 | 2016 | 38 |
About Keith Harshman
Keith Harshman is a scholar working on Molecular Biology, Genetics, Oncology, Epidemiology and Cancer Research, having authored 43 papers that have together received 5.0k indexed citations. Recurring topics across this work include Gene expression and cancer classification (4 papers), Plant Pathogens and Fungal Diseases (3 papers), Melanoma and MAPK Pathways (3 papers), Fungal and yeast genetics research (3 papers), Virus-based gene therapy research (3 papers), RNA Research and Splicing (3 papers), T-cell and B-cell Immunology (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (906 citations), Molecular Biology (3.2k citations), Aging (61 citations) and Cell Biology (462 citations). Keith Harshman has collaborated with scholars based in Switzerland, United States and Spain. Frequent co-authors include Mark H. Skolnick, Sean V. Tavtigian, Alexander Kamb, Jane Weaver-Feldhaus, Elisabeth Stockert, Rufus S. Day, Bruce E. Johnson, Nelleke A. Gruis, Qingyun Liu and W. Scott Moye‐Rowley. Their work appears in journals such as Nucleic Acids Research, Science, Eukaryotic Cell, BioTechniques and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.